Clinical research

Trials &
Evidence

Translating computational models and algorithmic systems into clinically validated orthopedic interventions with transparent endpoints and reproducible analysis.

Current studies

Prospective protocols evaluating orthopedic algorithms, implants, and rehabilitation systems.

NCT-OC-2025-002

Bayesian Digital Twin Monitoring Post-THA Rehabilitation

Measuring predictive accuracy of patient-specific revision risk models using continuous wearable telemetry and hierarchical Bayesian calibration.

Prospective cohort · Wearable IMU telemetry · Bayesian hierarchical modeling

NCT-OC-2024-003

Closed-Loop Haptic Feedback in Upper-Limb Prosthetics

Assessing whether closed-loop force reflection reduces prosthetic motor adjustment errors by at least 40% in daily-use tasks.

Crossover design · EMG and force sensing · Signal processing validation

NCT-OC-2024-004

Bio-Absorbable Magnesium-Zinc Fixation Devices

Confirming non-inferior osseointegration at twelve months versus titanium controls using micro-CT histomorphometry correlated to FEA models.

Multi-center RCT · Micro-CT histomorphometry · FEA-correlated outcomes

Scientific governance

Standards that govern protocol design, data handling, and regulatory compliance.

IRB and ethics

All protocols are approved by institutional review boards. Informed consent follows ICH-GCP E6(R2) guidelines with adaptive designs pre-registered before enrollment.

Data integrity

Electronic data capture with audit trails, cryptographic hashing of raw streams, and FAIR-compliant metadata for reproducible analysis.

Regulatory alignment

Trial designs align with FDA 21 CFR Part 11, EU MDR clinical evaluation requirements, and ISO 14155 good clinical practice.

Statistical rigor

Pre-specified analysis plans, multiplicity correction, Bayesian interim analyses, and external adjudication of primary endpoints.

Partnerships

Interested in collaboration?

Partner hospitals, investigators, and patient advocates are welcome to connect with our clinical affairs team about trial participation and research partnerships.

Response within two business days